BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 6603573)

  • 21. Helical conformation at the carboxy-terminal portion of human C3a is required for full activity.
    Hoeprich PD; Hugli TE
    Biochemistry; 1986 Apr; 25(8):1945-50. PubMed ID: 3486674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pulmonary injury induced by C3a and C5a anaphylatoxins.
    Stimler NP; Hugli TE; Bloor CM
    Am J Pathol; 1980 Aug; 100(2):327-48. PubMed ID: 6967702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of C3a and C5a anaphylatoxins on guinea-pig isolated blood vessels.
    Marceau F; Hugli TE
    J Pharmacol Exp Ther; 1984 Sep; 230(3):749-54. PubMed ID: 6332191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional activities of synthetic anaphylatoxic peptides in widely used biological assays.
    Kola A; Klos A; Bautsch W; Kretzschmar T; Köhl J
    Clin Exp Immunol; 1992 May; 88(2):368-72. PubMed ID: 1572104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for a role of the amino-terminal region in the biological activity of the classical anaphylatoxin, porcine C5a des-Arg-74.
    Gerard C; Showell HJ; Hoeprich PD; Hugli TE; Stimler NP
    J Biol Chem; 1985 Mar; 260(5):2613-6. PubMed ID: 3972798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary structure of murine major histocompatibility complex alloantigens: amino acid sequence of the amino-terminal one hundred and seventy-three residues of the H-2Kb glycoprotein.
    Uehara H; Ewenstein BM; Martinko JM; Nathenson SG; Coligan JE; Kindt TJ
    Biochemistry; 1980 Jan; 19(2):306-15. PubMed ID: 6986168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative structural anatomy of the complement anaphylatoxin proteins C3a, C4a and C5a.
    Greer J
    Enzyme; 1986; 36(1-2):150-63. PubMed ID: 3491754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppression of humoral immune responses by synthetic C3a peptides.
    Morgan EL; Weigle WO; Erickson BW; Fok KF; Hugli TE
    J Immunol; 1983 Nov; 131(5):2258-61. PubMed ID: 6355293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Partial characterization of human C5a anaphylatoxin. I. Chemical description of the carbohydrate and polypeptide prtions of human C5a.
    Fernandez HN; Hugli TE
    J Immunol; 1976 Nov; 117(5 Pt 1):1688-94. PubMed ID: 1002996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural characterization of the C4a anaphylatoxin from rat.
    Cui L; Ferreri K; Hugli TE
    Mol Immunol; 1988 Jul; 25(7):663-71. PubMed ID: 3262196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A synthetic nonapeptide corresponding to the NH2-terminal sequence of C3d-K causes leukocytosis in rabbits.
    Hoeprich PD; Dahinden CA; Lachmann PJ; Davis AE; Hugli TE
    J Biol Chem; 1985 Mar; 260(5):2597-600. PubMed ID: 3871772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mast cells are not required for anaphylatoxin-induced ileal smooth muscle contraction.
    Stimler-Gerard NP; Galli SJ
    J Immunol; 1987 Mar; 138(6):1908-13. PubMed ID: 2434565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of human anaphylatoxins on guinea pig atria.
    Huey R; Bloor CM; Hugli TE
    Immunopharmacology; 1984 Dec; 8(3-4):147-54. PubMed ID: 6335143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The anaphylatoxic peptide C3a of guinea pig complement. I. Purification, physicochemical and antigenetic properties.
    Meuer S; Becker S; Hadding U; Bitter-Suermann D
    Z Immunitatsforsch Immunobiol; 1978 Mar; 154(2):135-46. PubMed ID: 77089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anaphylatoxin C3a peptide contracts human pulmonary vasculature.
    Schellenberg RR; Mullen JB; Foster A; Glovsky MM
    Pulm Pharmacol; 1988; 1(3):133-8. PubMed ID: 2980296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The primary structure of porcine C3a anaphylatoxin.
    Corbin NC; Hugli TE
    J Immunol; 1976 Sep; 117(3):990-5. PubMed ID: 956663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of human C4a anaphylatoxin.
    Gorski JP; Hugli TE; Müller-Eberhard HJ
    J Biol Chem; 1981 Mar; 256(6):2707-11. PubMed ID: 6970745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biologic activity of a C2-derived peptide. Demonstration of a specific interaction with guinea pig lung tissues.
    Cholin S; Gerard NP; Strang CJ; Davis AE
    J Immunol; 1989 Apr; 142(7):2401-4. PubMed ID: 2926138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary and tertiary structure of the principal human adenylate kinase.
    Von Zabern I; Wittmann-Liebold B; Untucht-Grau R; Schirmer RH; Pai EF
    Eur J Biochem; 1976 Sep; 68(1):281-90. PubMed ID: 183954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The structural basis for anaphylatoxin and chemotactic functions of C3a, C4a, and C5a.
    Hugli TE
    Crit Rev Immunol; 1981 Feb; 1(4):321-66. PubMed ID: 7037298
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.